Datar Genetics Ltd has joined hands with Apollo Hospitals to provide Precision Oncology, a cancer management technique which brings down pain and lowers costs. The partnership envisages the integration of molecular and genetic analysis in the diagnosis, treatment and monitoring of cancers. The collaboration shall further explore leveraging technology to introduce precision matching for organ/bone marrow transplants.
Dr. K Hariprasad, Group President, Apollo Hospitals said, " Precision diagnosis gives patients the best chance to fight cancer upfront, save costs, reduce suffering and reduce time to productivity. We intend to turn a page in cancer management by introducing Precision Oncology across Apollo Hospitals. With the evolution of molecular diagnostics and genetics, it's time to leverage technology to enable precision diagnosis and commensurate treatment giving the patient the best chance to fight cancer. This in turn shall enable us to realize our long standing vision of delivering better clinical outcomes from bench to bedside. This alliance is further validation of Apollo Hospital's commitment to research driven health care."
Also speaking on the occasion, Rajan Datar, Managing Director, Datar Genetics, said “It is inevitable that genetics will be the main stay of all aspects of the war on cancer. India will lead this intellectual revolution and Datar Genetics is determined to make it successful. The collaboration with Apollo Hospitals marks the fundamental shift from a ‘West-facing’ and ‘West-dependent’ perspective in high technology in healthcare to a self-confident research initiative in India."
The strategic partnership is the first of its kind in India and will pave the way for rapid integration of molecular and genetic analysis as standard treatment options in cancer treatment for better outcomes and quality of life for patients as well as create an India centric model for high technology relevant for the world.
Date:27th November 2016
Venue: Auditorium, Indraprastha Apollo Hospitals, New Delhi